In patients with heart failure and secondary mitral valve regurgitation, transcatheter edge-to-edge repair is non-inferior to mitral valve surgery with respect to a composite of death, hospitalization for heart failure, reintervention, implantation of an assist device or stroke at 1 year after the procedure, according to findings from the MATTERHORN trial.

中文翻译：

---

对于继发性二尖瓣反流患者，TEER 不劣于手术


根据 MATTERHORN 试验的结果，在心力衰竭和继发性二尖瓣反流患者中，经导管边对边修复在手术后 1 年死亡、因心力衰竭住院、再次干预、植入辅助装置或中风的综合方面不劣于二尖瓣手术。